Skip to main content
. Author manuscript; available in PMC: 2011 May 9.
Published in final edited form as: Crit Care Med. 2008 Sep;36(9):2511–2516. doi: 10.1097/CCM.0b013e318183f608

Figure 1.

Figure 1

Distribution of survivors and nonsurvivors based on surfactant protein B gene (SFTP-B) genotype. For patients with wildtype SFTP-B, 98 patients (56%) survived and 77 (44%) died. For patients with variable nuclear tandem repeat (VNTR) SFTP-B polymorphism, 17 patients (44%) survived and 22 (56%) died.